Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
Lifecore Biomedical (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), has announced its participation in three major upcoming conferences in March 2025.
The company will participate in the TD Cowen 45th Annual Health Care Conference in Boston (March 3-5), where CEO Paul Josephs will deliver a corporate presentation on March 4. Additionally, Lifecore will attend the KeyBanc Capital Markets Healthcare Forum (March 18-19) virtually, featuring a fireside chat with Mr. Josephs on March 19.
The company will also participate in DCAT Week 2025 in New York (March 17-20), engaging with current and prospective customers. A live webcast of the TD Cowen presentation will be available on Lifecore's investor website, with a replay accessible post-conference.
Lifecore Biomedical (NASDAQ: LFCR), un'organizzazione completamente integrata di sviluppo e produzione a contratto (CDMO), ha annunciato la sua partecipazione a tre importanti conferenze in programma per marzo 2025.
L'azienda parteciperà al 45° Convegno Annuale sulla Salute di TD Cowen a Boston (dal 3 al 5 marzo), dove il CEO Paul Josephs presenterà un intervento aziendale il 4 marzo. Inoltre, Lifecore parteciperà virtualmente al Healthcare Forum di KeyBanc Capital Markets (dal 18 al 19 marzo), con una chiacchierata informale con il signor Josephs il 19 marzo.
L'azienda parteciperà anche alla DCAT Week 2025 a New York (dal 17 al 20 marzo), interagendo con clienti attuali e potenziali. Una diretta streaming della presentazione di TD Cowen sarà disponibile sul sito web per gli investitori di Lifecore, con una registrazione accessibile dopo la conferenza.
Lifecore Biomedical (NASDAQ: LFCR), una organización de desarrollo y fabricación por contrato (CDMO) completamente integrada, ha anunciado su participación en tres importantes conferencias programadas para marzo de 2025.
La empresa participará en la 45ª Conferencia Anual de Salud de TD Cowen en Boston (del 3 al 5 de marzo), donde el CEO Paul Josephs ofrecerá una presentación corporativa el 4 de marzo. Además, Lifecore asistirá virtualmente al Foro de Salud de KeyBanc Capital Markets (del 18 al 19 de marzo), que contará con una charla informal con el Sr. Josephs el 19 de marzo.
La empresa también participará en la DCAT Week 2025 en Nueva York (del 17 al 20 de marzo), interactuando con clientes actuales y potenciales. Una transmisión en vivo de la presentación de TD Cowen estará disponible en el sitio web de inversores de Lifecore, con una repetición accesible después de la conferencia.
Lifecore Biomedical (NASDAQ: LFCR), 완전 통합된 계약 개발 및 제조 조직(CDMO), 2025년 3월에 예정된 세 가지 주요 컨퍼런스에 참여한다고 발표했습니다.
회사는 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 컨퍼런스에 참석하며 (3월 3-5일), CEO Paul Josephs가 3월 4일에 기업 발표를 진행할 예정입니다. 또한 Lifecore는 KeyBanc Capital Markets 헬스케어 포럼 (3월 18-19일)에 가상으로 참석하며, 3월 19일에 Josephs 씨와의 대담이 예정되어 있습니다.
회사는 또한 뉴욕에서 열리는 DCAT Week 2025 (3월 17-20일)에 참여하여 현재 및 잠재 고객들과 소통할 예정입니다. TD Cowen 발표의 라이브 웹캐스트는 Lifecore의 투자자 웹사이트에서 제공되며, 컨퍼런스 후에는 재생이 가능합니다.
Lifecore Biomedical (NASDAQ: LFCR), une organisation de développement et de fabrication sous contrat (CDMO) entièrement intégrée, a annoncé sa participation à trois grandes conférences prévues en mars 2025.
L'entreprise participera à la 45ème Conférence Annuelle sur la Santé de TD Cowen à Boston (du 3 au 5 mars), où le PDG Paul Josephs présentera une intervention d'entreprise le 4 mars. De plus, Lifecore assistera virtuellement au Forum de Santé de KeyBanc Capital Markets (du 18 au 19 mars), avec une discussion informelle avec M. Josephs le 19 mars.
L'entreprise participera également à la DCAT Week 2025 à New York (du 17 au 20 mars), en interagissant avec des clients actuels et potentiels. Une diffusion en direct de la présentation de TD Cowen sera disponible sur le site des investisseurs de Lifecore, avec un replay accessible après la conférence.
Lifecore Biomedical (NASDAQ: LFCR), ein vollständig integriertes Auftragsentwicklungs- und Herstellungsunternehmen (CDMO), hat seine Teilnahme an drei wichtigen Konferenzen im März 2025 angekündigt.
Das Unternehmen wird an der 45. jährlichen Gesundheitskonferenz von TD Cowen in Boston (3. bis 5. März) teilnehmen, wo CEO Paul Josephs am 4. März eine Unternehmenspräsentation halten wird. Zudem wird Lifecore virtuell am Healthcare Forum von KeyBanc Capital Markets (18. bis 19. März) teilnehmen, das ein Gespräch am Kamin mit Herrn Josephs am 19. März umfasst.
Das Unternehmen wird auch an der DCAT Week 2025 in New York (17. bis 20. März) teilnehmen und mit aktuellen und potenziellen Kunden interagieren. Ein Live-Stream der TD Cowen-Präsentation wird auf der Investorenseite von Lifecore verfügbar sein, mit einer Wiederholung, die nach der Konferenz zugänglich ist.
- None.
- None.
CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences and industry events. Details regarding Lifecore’s participation are as follows:
- TD Cowen 45th Annual Health Care Conference
Details: Paul Josephs, chief executive officer, will deliver a corporate presentation and Lifecore management will participate in investor meetings
Presentation Date/Time: Tuesday, March 4, 2025, 9:50 – 10:20 a.m. ET
Conference Dates: March 3-5, 2025
Location: Boston, MA
- KeyBanc Capital Markets Healthcare Forum
Details: Mr. Josephs will participate in a fireside chat and Lifecore management will participate in investor meetings
Fireside Chat Date/Time: Wednesday, March 19, 2025, 3:00 – 3:35 p.m. ET
Conference Dates: March 18-19, 2025
Location: Virtual
- DCAT Week 2025
Details: Lifecore team will participate in meetings with current and prospective customers and attend networking events
Conference Dates: March 17-20, 2025
Location: New York, NY
A live webcast of the TD Cowen presentation may be accessed via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
FAQ
What conferences will Lifecore Biomedical (LFCR) attend in March 2025?
When is Paul Josephs' presentation at the TD Cowen conference for LFCR?
How can investors watch Lifecore's (LFCR) TD Cowen conference presentation?
What is the schedule for LFCR's KeyBanc Capital Markets Healthcare Forum fireside chat?
What activities will Lifecore (LFCR) conduct during DCAT Week 2025?
